Reports and Briefs on Pharmaceuticals

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Dainippon Sumitomo Ph. Co., Ltd: PharmaVitae Report

Analysis of Dainippon Sumitomo's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
06 May 2011 $2800
Buy
Report
Report

Genzyme Corporation: PharmaVitae Report

Analysis of Genzyme's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
06 May 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry

Global analysis of socio-demographic and economic trends, rising healthcare costs, intensifying cost-containment and regulatory pressures, the patent cliff as well insight into the pharmaceutical industry’s strategic responses to drive profitability.

Published By Datamonitor
20 May 2011 $1520
Buy
Report
Report

F. Hoffmann-La Roche Ltd: PharmaVitae Report

Analysis of Roche's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
06 Jun 2011 $2800
Buy
Report
Report

Cephalon Inc.: PharmaVitae Report

Analysis of Cephalon's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
10 Jun 2011 $2800
Buy
Report
Report

Amgen Inc.: PharmaVitae Report

Analysis of Amgen's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Jun 2011 $2800
Buy
Report
Report

Eli Lilly & Co.: PharmaVitae Report

Analysis of Eli Lilly's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Biogen Idec Inc.: PharmaVitae Report

Analysis of Biogen Idec's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Forest Laboratories Inc.: PharmaVitae Report

Analysis of Forest's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Sanofi: PharmaVitae Report

Analysis of Sanofi corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.